Pharmerging Market Trends
An increase in the number of private hospitals
An increase in the number of private hospitals and an increase in healthcare spending are currently driving the growth of the global pharmaceutical industry. The market is growing due to the high prevalence of a number of chronic diseases and increasing consumer awareness of early disease diagnosis and treatment techniques. The need for pharmaceuticals is also growing as a result of the aging population, which is more vulnerable to severe conditions like dementia, hypertension, heart failure, etc.
The primary driver of the growth in pharmaceutical markets is the growing need for generic medications due to financial difficulties. It is predicted that supportive government policies for localization will serve as pull factors for manufacturers of generic products instead of those of unique products. Globally, the aging population is affecting this industry in various ways. By 2030, estimates suggest that one in six persons will be over 60. China is expected to have 330 million senior citizens by 2050, whereas India will have 277 million older citizens. The three most common ailments among the elderly are heart failure, hypertension, and dementia. These conditions require long-term, continuous treatment. Given the increasing number of senior citizens, there is a greater demand for home healthcare and second care. More of these institutions are now in countries like Brazil, China, and India. These facilities may be supported by public or private finance. To lower the cost of treating chronic diseases, Tier I and Tier II governments have also raised healthcare spending and are putting supportive policies into place.